Cyteir Therapeutics
$3.02
6
-$0.07-2.27% Friday 20:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Dividends
0%Dividend Yield
Nov 15
$0.13
Aug 15
$0.13
May 15
$0.13
Feb 15
$0.13
Nov 14
$0.13
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A
Earnings
13MarExpected
Expected EPS
-0.25
Actual EPS
0
Financials
-Profit Margin
Unprofitable0Revenue
-46.06MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CYT. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company is also developing CYT-1853, which is in preclinical trials for solid tumors and hematologic malignancies. The company was incorporated in 2012 and is based in Lexington, Massachusetts.
Show more...
CEO
Employees
46
Country
US
ISIN
US23284P1030
Listings
0 Comments
Share your thoughts
FAQ
What is Cyteir Therapeutics stock price today?▼
The current price of CYT is $3.02 USD — it has decreased by -2.27% in the past 24 hours. Watch Cyteir Therapeutics stock price performance more closely on the chart.
What is Cyteir Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cyteir Therapeutics stocks are traded under the ticker CYT.
What were Cyteir Therapeutics earnings last quarter?▼
CYT earnings for the last quarter are 0 USD per share, whereas the estimation was -0.25 USD resulting in a +100% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cyteir Therapeutics revenue for the last year?▼
Cyteir Therapeutics revenue for the last year amounts to 0 USD.
What is Cyteir Therapeutics net income for the last year?▼
CYT net income for the last year is -46.06M USD.
Does Cyteir Therapeutics pay dividends?▼
Yes, CYT dividends are paid quarterly. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Cyteir Therapeutics have?▼
As of April 04, 2026, the company has 46 employees.
In which sector is Cyteir Therapeutics located?▼
Cyteir Therapeutics operates in the Manufacturing sector.
When did Cyteir Therapeutics complete a stock split?▼
Cyteir Therapeutics has not had any recent stock splits.